PPAR agonists can induce browning of WAT, and administration of a PPARα agonist (fenofibrate) showed effective control of hypertriglyceridemia and reduction of adipose tissue in a patient with MSL (66). This evidence concerns the gene PPARA and hypertriglyceridemia.